Diagnostic challenges in patients with suspected Lyme neuroborreliosis

Authors

  • I. M. Poiasnyk Ivano-Frankivsk National Medical University, Ukraine,

DOI:

https://doi.org/10.14739/2310-1210.2020.2.200654

Keywords:

Lyme neuroborreliosis, early diagnosis, late diagnosis

Abstract

 

Lyme neuroborreliosis is a tick–borne spirochetal infection, which may affect the peripheral or central nervous system at the early or late stages of the disease.

The purpose of the work is to analyze modern scientific literature on the issues of clinical manifestations, diagnostics of early and late Lyme neuroborreliosis.

Analysis of the scientific literature related to the diagnosis of Lyme neuroborreliosis was carried out. According to the authors of the researches, it was found that clinical presentation varies with disease stage, and Lyme neuroborreliosis is reported in up to 25 % of patients with Lyme disease. The clinical manifestations of this not uncommon disorder nowadays depend on the neurological structures which are primarily involved. The full clinical picture of Lyme neuroborreliosis may mimic other diseases, so atypical symptoms can result in diagnostic delay or misdiagnosis.

Conclusions. The incidence of Lyme neuroborreliosis seems to be much higher than previously assumed. Cerebrospinal fluid examination (detection of Borrelia burgdorferi IgM and IgG specific antibodies) is essential for the diagnosis of early and late Lyme neuroborreliosis, as successful treatment of early Lyme neuroborreliosis can prevent the expensive and devastating consequences of late Lyme neuroborreliosis.

References

  1. Hofmann, H., Fingerle, V., Hunfeld, K.-P., Huppertz, H.-I., Krause, A., Rauer, S., Ruf, B., & Consensus group. (2017). Cutaneous Lyme borreliosis: Guideline of the German Dermatology Society. GMS German Medical Science, 15, Article Doc14. https://doi.org/10.3205/000255
  2. Sprong, H., Hofhuis, A., Gassner, F., Takken, W., Jacobs, F., van Vliet, A. J. H., van Ballegooijen, M., van der Giessen, J., & Takumi, K. (2012). Circumstantial evidence for an increase in the total number and activity of borrelia-infected ixodes ricinus in the Netherlands. Parasites & Vectors, 5, Article 294. https://doi.org/10.1186/1756-3305-5-294
  3. Ruyts, S. C., Ampoorter, E., Coipan, E. C., Baeten, L., Heylen, D., Sprong, H., Matthysen, E., & Verheyen, K. (2016). Diversifying forest communities may change Lyme disease risk: extra dimension to the dilution effect in Europe. Parasitology, 143(10), 1310-1319. https://doi.org/10.1017/s0031182016000688
  4. Hobbs, R. (2009). Woodland restoration in Scotland: Ecology, history, culture, economics, politics and change. Journal of Environmental Management, 90(9), 2857-2865. https://doi.org/10.1016/j.jenvman.2007.10.014
  5. Kauppi, P. E., Ausubel, J. H., Fang, J., Mather, A. S., Sedjo, R. A., Waggoner, P. E. (2006). Returning forests analyzed with the forest identity. Proceedings of the National Academy of Sciences, 103(46), 17574-17579. https://doi.org/10.1073/pnas.0608343103
  6. Hansford, K. M., Fonville, M., Gillingham, E. L., Coipan, E. C., Pietzsch, M. E., Krawczyk, A. I., Vaux, A. G. C., Cull, B., Sprong, H., & Medlock, J. M. (2017). Ticks and Borrelia in urban and peri-urban green space habitats in a city in southern England. Ticks and Tick-Borne Diseases, 8(3), 353-361. https://doi.org/10.1016/j.ttbdis.2016.12.009
  7. Paul, R. E. L., Cote, M., Le Naour, E., & Bonnet, S. I. (2016). Environmental factors influencing tick densities over seven years in a French suburban forest. Parasites & Vectors, 9(1), Article 309. https://doi.org/10.1186/s13071-016-1591-5
  8. Vourc’h, G., Abrial, D., Bord, S., Jacquot, M., Masséglia, S., Poux, V., Pisanu, B., Bailly, X., & Chapuis, J.-L. (2016). Mapping human risk of infection with Borrelia burgdorferi sensu lato, the agent of Lyme borreliosis, in a periurban forest in France. Ticks and Tick-Borne Diseases, 7(5), 644-652. https://doi.org/10.1016/j.ttbdis.2016.02.008
  9. Stanek, G., Fingerle, V., Hunfeld, K.-P., Jaulhac, B., Kaiser, R., Krause, A., Kristoferitsch, W., O’Connell, S., Ornstein, K., Strle, F., & Gray, J. (2011). Lyme borreliosis: Clinical case definitions for diagnosis and management in Europe. Clinical Microbiology and Infection, 17(1), 69-79. https://doi.org/10.1111/j.1469-0691.2010.03175.x
  10. Borchers, A. T., Keen, C. L., Huntley, A. C., & Gershwin, M. E. (2015). Lyme disease: A rigorous review of diagnostic criteria and treatment. Journal of Autoimmunity, 57, 82-115. https://doi.org/10.1016/j.jaut.2014.09.004
  11. Stanek, G., O'Connell, S., Cimmino, M., Aberer, E., Kristoferitsch, W., Granström, M., Guy, E., & Gray, J. (1996). European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis. Wiener klinische Wochenschrift, 108(23), 741-747.
  12. Strle, F., Nelson, J. A., Ruzic-Sabljic, E., Cimperman, J., Maraspin, V., Lotric-Furlan, S., Cheng, Y., Picken, M. M., Trenholme, G. M., & Picken, R. N. (1996). European Lyme Borreliosis: 231 Culture-Confirmed Cases Involving Patients with Erythema Migrans. Clinical Infectious Diseases, 23(1), 61-65. https://doi.org/10.1093/clinids/23.1.61
  13. Strle, F., Videcnik, J., Zorman, P., Cimperman, J., Lotric-Furlan, S., & Maraspin, V. (2002). Clinical and epidemiological findings for patients with erythema migrans. Comparison of cohorts from the years 1993 and 2000. Wiener klinische Wochenschrift, 114(13-14), 493-497.
  14. Nadelman, R. B. (2015). Erythema Migrans. Infectious Disease Clinics of North America, 29(2), 211-239. https://doi.org/10.1016/j.idc.2015.02.001
  15. Maraspin, V., Cimperman, J., Lotric-Furlan, S., Ruzić-Sabljić, E., Jurca, T., Picken, R. N., & Strle, F. (2002). Solitary borrelial lymphocytoma in adult patients. Wiener klinische Wochenschrift, 114(13-14), 515-523.
  16. Asbrink, E., & Hovmark, A. (1988). Early and Late Cutaneous Manifestations in Ixodes-borne Borreliosis (Erythema Migrans Borreliosis, Lyme Borreliosis). Annals of the New York Academy of Sciences, 539(1), 4-15. https://doi.org/10.1111/j.1749-6632.1988.tb31833.x
  17. Müllegger, R. R., & Glatz, M. (2008). Skin Manifestations of Lyme Borreliosis. American Journal of Clinical Dermatology, 9(6), 355-368. https://doi.org/10.2165/0128071-200809060-00002
  18. Brehmer-Andersson, E., Hovmark, A., & Asbrink, E. (1998). Acrodermatitis Chronica Atrophicans: Histopathologic Findings and Clinical Correlations in 111 Cases. Acta Dermato-Venereologica, 78(3), 207-213. https://doi.org/10.1080/000155598441558
  19. Kristoferitsch, W., Sluga, E., Graf, M., Partsch, H., Neumann, R., Stanek, G., & Budka, H. (1988). Neuropathy Associated with Acrodermatitis Chronica Atrophicans Clinical and Morphological Features. Annals of the New York Academy of Sciences, 539(1), 35-45. https://doi.org/10.1111/j.1749-6632.1988.tb31836.x
  20. Kindstrand, E., Nilsson, B. Y., Hovmark, A., Nennesmo, I., Pirskanen, R., Solders, G., & Asbrink, E. (2000). Polyneuropathy in late Lyme neuroborreliosis – a clinical, neurophysiological and morphological description. Acta Neurologica Scandinavica, 101(1), 47-52.
  21. Mygland, A., Ljøstad, U., Fingerle, V., Rupprecht, T., Schmutzhard, E., & Steiner, I. (2009). EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. European Journal of Neurology, 17(1), 8-16. https://doi.org/10.1111/j.1468-1331.2009.02862.x
  22. Steere, A. C. (2001). Lyme Disease. New England Journal of Medicine, 345(2), 115-125. https://doi.org/10.1056/nejm200107123450207
  23. Halperin, J. J. (2015). Nervous System Lyme Disease. Infectious Disease Clinics of North America, 29(2), 241-253. https://doi.org/10.1016/j.idc.2015.02.002
  24. Ogrinc, K., Lusa, L., Lotrič-Furlan, S., Bogovič, P., Stupica, D., Cerar, T., Ružić-Sabljić, E., & Strle, F. (2016). Course and Outcome of Early European Lyme Neuroborreliosis (Bannwarth Syndrome): Clinical and Laboratory Findings. Clinical Infectious Diseases, 63(3), 346-353. https://doi.org/10.1093/cid/ciw299
  25. Molins, C. R., Ashton, L. V., Wormser, G. P., Andre, B. G., Hess, A. M., Delorey, M. J., Pilgard, M. A., Johnson, B. J., Webb, K., Islam, M. N., Pegalajar-Jurado, A., Molla, I., Jewett, M. W., & Belisle, J. T. (2017). Metabolic differentiation of early Lyme disease from southern tick-associated rash illness (STARI). Science Translational Medicine, 9(403), Article eaal2717. https://doi.org/10.1126/scitranslmed.aal2717
  26. Ljøstad, U., Skarpaas, T., & Mygland, Å. (2007). Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis. European Journal of Neurology, 14(8), 873-876. https://doi.org/10.1111/j.1468-1331.2007.01799.x
  27. Hammers-Berggren, S., Hansen, K., Lebech, A.-M., & Karlsson, M. (1993). Borrelia burgdorferi‐specific intrathecal antibody production in neuroborreliosis. Neurology, 43(1 Pt. 1), 169-175. https://doi.org/10.1212/wnl.43.1_part_1.169
  28. OʼConnell, S. (2010). Lyme borreliosis: current issues in diagnosis and management. Current Opinion in Infectious Diseases, 23(3), 231-235. https://doi.org/10.1097/qco.0b013e32833890e2
  29. Skogman, B. H., Croner, S., Nordwall, M., Eknefelt, M., Ernerudh, J., & Forsberg, P. (2008). Lyme Neuroborreliosis in Children. The Pediatric Infectious Disease Journal, 27(12), 1089-1094. https://doi.org/10.1097/inf.0b013e31817fd423
  30. Skeie, G. O., Eldøen, G., Skeie, B. S., Midgard, R., Kristoffersen, E. K., & Bindoff, L. A. (2007). Opsoclonus myoclonus syndrome in two cases with neuroborreliosis. European Journal of Neurology, 14(12), Article e1-e2. https://doi.org/10.1111/j.1468-1331.2007.01959.x
  31. Țilea, B., Bălașa, R., Fodor, A., & Țilea, I. (2016). Diagnosis and Treatment Algorythm in Lyme Neuroborreliosis. Acta Medica Marisiensis, 62(1), 121-127. https://doi.org/10.1515/amma-2015-0125
  32. Wormser, G. P., Dattwyler, R. J., Shapiro, E. D., Halperin, J. J., Steere, A. C., Klempner, M. S., Krause, P. J., Bakken, J. S., Strle, F., Stanek, G., Bockenstedt, L., Fish, D., Dumler, J. S., & Nadelman, R. B. (2006). The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases, 43(9), 1089-1134. https://doi.org/10.1086/508667
  33. Halperin, J. J. (1995). Neuroborreliosis. The American Journal of Medicine, 98(4 Suppl. 1), 52S-59S. https://doi.org/10.1016/s0002-9343(99)80044-8
  34. Sprong, H., Azagi, T., Hoornstra, D., Nijhof, A. M., Knorr, S., Baarsma, M. E., & Hovius, J. W. (2018). Control of Lyme borreliosis and other Ixodes ricinus-borne diseases. Parasites & Vectors, 11(1), Article 145. https://doi.org/10.1186/s13071-018-2744-5
  35. Ljøstad, U., Skogvoll, E., Eikeland, R., Midgard, R., Skarpaas, T., Berg, Å., & Mygland, Å. (2008). Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. The Lancet Neurology, 7(8), 690-695. https://doi.org/10.1016/s1474-4422(08)70119-4
  36. Kruger, H., Reuss, K., Pulz, M., Rohrbach, E., Pflughaupt, K.-W., Martin, R., & Mertens, H. G. (1989). Meningoradiculitis and encephalomyelitis due to Borrelia burgdorferi: a follow-up study of 72 patients over 27 years. Journal of Neurology, 236(6), 322-328. https://doi.org/10.1007/bf00314373
  37. Dersch, R., Toews, I., Sommer, H., Rauer, S., & Meerpohl, J. J. (2015). Methodological quality of guidelines for management of Lyme neuroborreliosis. BMC Neurology, 15, Article 242. https://doi.org/10.1186/s12883-015-0501-3
  38. Dessau, R. B., van Dam, A. P., Fingerle, V., Gray, J., Hovius, J. W., Hunfeld, K.-P., Jaulhac, B., Kahl, O., Kristoferitsch, W., Lindgren, P.-E., Markowicz, M., Mavin, S., Ornstein, K., Rupprecht, T., Stanek, G., & Strle, F. (2018). To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis. Clinical Microbiology and Infection, 24(2), 118-124. https://doi.org/10.1016/j.cmi.2017.08.025
  39. Taba, P., Schmutzhard, E., Forsberg, P., Lutsar, I., Ljøstad, U., Mygland, Å., Levchenko, I., Strle, F., & Steiner, I. (2017). EAN consensus review on prevention, diagnosis and management of tick-borne encephalitis. European Journal of Neurology, 24(10), 1214-e61. https://doi.org/10.1111/ene.13356
  40. Oschmann, P., Dorndorf, W., Hornig, C., Schäfer, C., Wellensiek, H. J., & Pflughaupt, K. W. (1998). Stages and syndromes of neuroborreliosis. Journal of Neurology, 245(5), 262-272. https://doi.org/10.1007/s004150050216
  41. Mygland, Å., Skarpaas, T., & Ljøstad, U. (2006). Chronic polyneuropathy and Lyme disease. European Journal of Neurology, 13(11), 1213-1215. https://doi.org/10.1111/j.1468-1331.2006.01395.x
  42. Topakian, R., Stieglbauer, K., Nussbaumer, K., & Aichner, F. T. (2008). Cerebral Vasculitis and Stroke in Lyme Neuroborreliosis. Cerebrovascular Diseases, 26(5), 455-461. https://doi.org/10.1159/000155982
  43. Charles, V., Duprez, T. P., Kabamba, B., Ivanoiu, A., & Sindic, C. J. M. (2007). Poliomyelitis-like syndrome with matching magnetic resonance features in a case of Lyme neuroborreliosis. Journal of Neurology, Neurosurgery & Psychiatry, 78(10), 1160-1161. https://doi.org/10.1136/jnnp.2007.121103
  44. Beuchat, I., Dunet, V., Meylan, P., & Du Pasquier, R. (2018). Late Lyme neuroborreliosis with chronic encephalomyelitis. Neurology, 91(13), 627-628. https://doi.org/10.1212/wnl.0000000000006252
  45. Schwenkenbecher, P., Pul, R., Wurster, U., Conzen, J., Pars, K., Hartmann, H., Sühs, K.-W., Sedlacek, L., Stangel, M., Trebst, C., & Skripuletz, T. (2017). Common and uncommon neurological manifestations of neuroborreliosis leading to hospitalization. BMC Infectious Diseases, 17(1), Article 90. https://doi.org/10.1186/s12879-016-2112-z
  46. Kristoferitsch, W., Aboulenein-Djamshidian, F., Jecel, J., Rauschka, H., Rainer, M., Stanek, G., & Fischer, P. (2018). Secondary dementia due to Lyme neuroborreliosis. Wiener Klinische Wochenschrift, 130(15-16), 468-478. https://doi.org/10.1007/s00508-018-1361-9
  47. Miklossy, J. (2012). Chronic or Late Lyme Neuroborreliosis: Analysis of Evidence Compared to Chronic or Late Neurosyphilis. The Open Neurology Journal, 6(Suppl. 1), 146-157. https://doi.org/10.2174/1874205x01206010146
  48. Lindland, E. S., Solheim, A. M., Andreassen, S., Quist-Paulsen, E., Eikeland, R., Ljøstad, U., Mygland, Å., Elsais, A., Nygaard, G. O., Lorentzen, Å. R., Harbo, H. F., & Beyer, M. K. (2018). Imaging in Lyme neuroborreliosis. Insights into Imaging, 9(5), 833-844. https://doi.org/10.1007/s13244-018-0646-x
  49. Halperin, J., Luft, B. J., Volkman, D. J., & Dattwyler, R. J. (1990). Lyme neuroborreliosis: Peripheral nervous system manifestations. Brain, 113(4), 1207-1221. https://doi.org/10.1093/brain/113.4.1207
  50. Rauer, S., Kastenbauer, S., Fingerle, V., Hunfeld, K.-P., Huppertz, H.-I., & Dersch, R. (2018). Lyme neuroborreliosis. Deutsches Aerzteblatt Online, 115(45), 751-756. https://doi.org/10.3238/arztebl.2018.0751

Downloads

How to Cite

1.
Poiasnyk IM. Diagnostic challenges in patients with suspected Lyme neuroborreliosis. Zaporozhye Medical Journal [Internet]. 2020Apr.13 [cited 2026May20];22(2). Available from: https://zmj.zsmu.edu.ua/article/view/200654

Issue

Vol. 22 No. 2 (2020)

Section

Review

License

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  Лицензия Creative Commons